Chronic Pain MedsCheck Trial
Pharmacy Search - Chronic Pain MedsCheck Trial
To be eligible, patients must be:
- Adults who are 18 years and over
- Have a Medicare and/or DVA card
- Taking over the counter medicine (eg. Ibuprofen or paracetamol) or prescription medicine to treat pain that has been present for three months or greater
- Based on patient self-report, have not received a MedsCheck or HMR in the previous 12 months
- In the pharmacist’s opinion, there is an opportunity to improve self-management or address dependency concerns
The final patient recruitment and initial service deadline has now been extended until 30 November 2019 and final patient follow up services will need to be completed 3 months later by the end of February 2020.
Patient recruitment extension
More patients from main sites are needed for this research trial. As little as five more patients recruited through main site pharmacies can make a great difference.
Trial pharmacies can also recruit and conduct initial services for more than 40 patients for the trial until 30 September 2019, and will be paid for all services conducted.
Payments for trial services start at $98.41 for the initial consultation for a main site, or at $162.21 for an evaluation site pharmacy. All evaluation site pharmacies also receive an additional one-off payment of $500 for the additional data collection and training required. Please see the Pharmacy/Pharmacist Information Statement for more details.
The Chronic Pain MedsCheck Trial is funded by the Australian Department of Health as part of the Sixth Community Pharmacy Agreement (6CPA) Pharmacy Trial Program (PTP).
The 6CPA PTP was established to trial new and expanded Community Pharmacy Programs that seek to improve clinical outcomes for consumers and by progressing the role of community pharmacies in the delivery of primary healthcare services.
The Chronic Pain MedsCheck Trial objective is to evaluate the efficacy of the Chronic Pain MedsCheck service in:
- preventing incorrect use and/or overuse of pain medication,
- increasing patients’ pain medication health literacy,
- improving their ability to self-manage their chronic pain, and;
- improving their overall quality of life
Community pharmacy registrations for the Chronic Pain MedsCheck Trial are now closed.
Pharmacies participating in the trial must register their pharmacists to complete the compulsory online training prior to conducting services. They will be required to collect data in the GuildCare NG software (where patient consent has been obtained) for at least 10 patients. Pharmacies will be reimbursed for all services they complete on the GuildcareNG software.
Further information including pharmacy trial payments can be found in the Pharmacy/Pharmacist Information Statement.
You can find the trial resources along the right hand side this page.
To help promote the Chronic Pain MedsCheck at your pharmacy, you can print out our poster and flyer. We have included a blank space at the bottom the the A5 Flyer 2019 – Blank document for you to add your pharmacy details to the flyer.
Pharmacy registrations for the trial are now closed. Notification of participation has been emailed to participating pharmacies with details of which group they have been randomly allocated into and next steps.
If any pharmacist of a participating pharmacy has not received their training access email from Guild Learning and Development, please contact the Chronic Pain MedsCheck Trial project team at email@example.com.
Training and Trial Software Access
The training modules are worth up to 7.5 Group 2 CPD points and are available through the GuildEd platform as an included part of the trial. The trial modules are clinician reviewed and tailored for community pharmacy. Everyone granted access can start the training modules through https://guilded.guild.org.au/ under the My Learning tab.
Once at least one (1) pharmacist from the participating pharmacy has been confirmed by the Chronic Pain MedsCheck Trial project team as having completed the training, GuildLink will then be notified to provide complimentary access to the Chronic Pain MedsCheck Trial Software for that pharmacy.
The Chronic Pain MedsCheck Trial project team will be sending out weekly confirmation emails to each pharmacy once we have confirmed that one pharmacist has completed training and that we will be notifying GuildLink to provide access to the Chronic Pain MedsCheck Trial Software for that pharmacy.
If any pharmacist of a participating pharmacy has not received email access to the training, please contact the Chronic Pain MedsCheck Trial project team at firstname.lastname@example.org to confirm details.
If a pharmacy agrees to participate, all pharmacists participating in the trial are obliged to complete free CPD accredited online training modules. The Chronic Pain MedsCheck Trial training program which will explain:
- the trial design,
- requirements of pharmacies in each group,
- types of patients that are suitable for invitation to the trial,
- suggested process for identifying patients that meet the trial criteria,
- the intervention process including data collection requirements.
In addition, pharmacies that are randomised to be an evaluation trial site will be involved in an additional free online CPD training accredited training session on the evaluation trial site specific requirements.
Once pharmacists have completed the training, the pharmacy will be asked to recruit and complete initial consultations on the GuildcareNG software for around 10 patients that meet the trial criteria until 30 June 2019.
The trial target population includes patients living with ongoing chronic pain for three or more months who may be experiencing self-management problems or pain medication dependency.
The Chronic Pain MedsCheck Trial is a Pharmacy Trial Program (PTP) that will trial the delivery of a specialised Chronic Pain MedsCheck within community pharmacy.
The trial intervention from community pharmacy will include:
- supported self -management of patients taking medication who are dealing with chronic pain for more than three months through pharmacist advice;
- pharmacy-based evaluation of patient’s medicine, and;
- provision of an action plan
- action plans will incorporate education, self-management and referral to other health professionals where additional support is required.
- three month follow up after the initial service
The Chronic Pain MedsCheck trial includes two randomly selected intervention groups, Group A and Group B:
Group A: Involves an initial in-pharmacy face-to-face consultation between the pharmacist and the consumer and a three month follow up consultation.
Group B: Involves an initial in-pharmacy face-to-face consultation between the pharmacist and the consumer; a six week midpoint follow up consultation by telephone, and a three month follow up consultation.
From each group will also be randomly selected a number of evaluation pharmacies, to provide additional information on the intervention. These pharmacies will provided appropriate remuneration for the additional request of their time, please see the Pharmacy/Pharmacist Information Statement for more details.
The Chronic Pain MedsCheck Trial service will include the provision of information about accessing additional support, or where appropriate a referral to the patients’ GP or allied health professional.
Community pharmacies delivering Chronic Pain MedsChecks will be encouraged to build relationships with other health professionals providing support for patients with chronic pain.
For more detail about the service, please read the Pharmacy/Pharmacist Information Statement.
Claims and Payments
The Chronic Pain MedsCheck Trial uses a passive claiming system. This means as long as you have completed all the required data correctly in the GuildcareNG software, you will be paid for services after data validation. There is no requirement to submit a claim for payment.
If any further information is required for payment, the project team will contact you.
You can call the Guild Trial Programs on 1300 555 262 or email email@example.com for any further queries.